Left Ventricular Systolic Dysfunction Associated With Pulmonary Hypertension Riociguat Trial (LEPHT)

被引：0
|
作者：
Semigran, Marc [1 ]
Bonderman, Diana [2 ]
Ghio, Stefano [3 ]
Felix, Stephan B. [4 ]
Ghofrani, Hossein A. [5 ]
Michelakis, Evangelos D. [6 ]
Mitrovic, Veselin [7 ]
Oudiz, Ronald J. [8 ]
Roessig, Lothar [9 ]
Scalise, Andrea V. [10 ]
机构：
[1] Massachusetts Gen Hosp, Heart Cntr, Boston, MA 02114 USA
[2] Med Univ Vienna, Vienna, Austria
[3] Fdn Policlin S Matteo, Pavia, Italy
[4] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[5] Univ Hosp Giessen & Marburg, Giessen, Germany
[6] Univ Alberta, Edmonton, AB, Canada
[7] Kerckhoff Heart Cntr, Bad Nauheim, Germany
[8] Harbor UCLA Med Cntr, Los Angeles Biomed Rsch Inst, Torrance, CA USA
[9] Bayer Pharma AG, Berlin, Germany
[10] Bayer Hispania SL, Barcelona, Spain
来源：
CIRCULATION | 2012年 / 126卷 / 23期
关键词：
Heart failure; Pulmonary hypertension; Vasodilator agents;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2789 / 2790
页数：2
相关论文
共 50 条
  • [1] Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design
    Ghio, Stefano
    Bonderman, Diana
    Felix, Stephan B.
    Ghofrani, Hossein A.
    Michelakis, Evangelos D.
    Mitrovic, Veselin
    Oudiz, Ronald J.
    Frey, Reiner
    Roessig, Lothar
    Semigran, Marc J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (08) : 946 - 953
  • [2] Pulmonary hypertension and right ventricular failure in left ventricular systolic dysfunction
    Di Salvo, Thomas G.
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (03) : 262 - 272
  • [3] Hemodynamic Predictors of Renal Dysfunction in Left Ventricular Systolic Dysfunction and Pulmonary Hypertension
    Purushottam, Bhaskar
    Gajanana, Deepakraj
    Janzer, Sean
    Morris, Dennis L.
    Figueredo, Vincent M.
    CIRCULATION, 2013, 128 (22)
  • [4] Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
    Wang, Li
    Zhu, Xinyi
    Zhao, Liang-Ping
    Wang, Maosong
    Liu, Xiang
    Chen, Yuqi
    Chen, JianChang
    Xu, WeiTing
    MEDICINE, 2019, 98 (16)
  • [5] Warfarin Use is Associated With Reduced Mortality in Patients with Left Ventricular Systolic Dysfunction and Pulmonary Hypertension
    Goudie, Andrew
    Elder, Douglas
    Robertson, Alan
    Struthers, Allan D.
    Lang, Chim
    Szwejkowski, Ben
    CIRCULATION, 2011, 124 (21)
  • [6] Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
    Wang, Li
    Zhao, Liangping
    Zhu, Xinyi
    Wang, Maosong
    Liu, Xiang
    Chen, JianChang
    Xu, Weiting
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C162 - C162
  • [7] Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction
    Wang, Li
    Zhao, Liang-Ping
    Chen, Yuqi
    Chang, Xiansong
    Jin, Fulu
    Liu, Xiang
    HERZ, 2021, 46 (06) : 575 - 580
  • [8] Warfarin use is associated with increased survival in patients with left ventricular systolic dysfunction and pulmonary hypertension
    Elder, D. H. J.
    Goudie, A.
    Szwejkowski, B.
    Choy, A.
    Struthers, A.
    Lang, C. C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 168 - 169
  • [9] Pulmonary hypertension associated with reversible left ventricular dysfunction
    Truebel, H.
    Kuhlebrock, K.
    Bugaj, T.
    Sabbah, H.
    Thomas, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [10] Pulmonary hypertension associated with Left ventricular diastolic dysfunction
    Fiack, Christopher A.
    Farber, Harrison W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : 230 - 231
12345